Quick Answer
Inspire Medical Systems, Inc. reported Diluted EPS of $4.89 per share for fiscal year 2025.
Inspire Medical Systems, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $4.89 | +179.4% |
| 2024 | $1.75 | +343.1% |
| 2023 | -$0.72 | +55.0% |
| 2022 | -$1.60 | -3.9% |
| 2021 | -$1.54 | +29.7% |
| 2020 | -$2.19 | -56.4% |
| 2019 | -$1.40 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.34 | -43.3% | +383.3% |
| June 30, 2025 | -$0.12 | -137.5% | -220.0% |
| March 31, 2025 | $0.10 | +129.4% | -83.3% |
| September 30, 2024 | $0.60 | +306.9% | +87.5% |
| June 30, 2024 | $0.32 | +178.0% | +194.1% |
| March 31, 2024 | -$0.34 | +35.8% | -17.2% |
| September 30, 2023 | -$0.29 | +51.7% | +29.3% |
| June 30, 2023 | -$0.41 | +22.6% | +22.6% |
- Inspire Medical Systems, Inc. showed an increase of +179.4% in Diluted EPS compared to the prior fiscal year.
- Over the 2019–2025 period, Inspire Medical Systems, Inc.’s diluted eps has grown by 449.3% (from $1.40 per share (loss) to $4.89 per share).
- The most recent figure is from Inspire Medical Systems, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: